Skip to main content
Clinical Trials/ISRCTN17892113
ISRCTN17892113
Completed
未知

Pilot study to determine the oral health and levels of volatile sulphur compounds (VSCs) in the breath of human volunteers before and after cigarette and e-cigarette product use, using SIFT-MS and OralChroma

British American Tobacco0 sites33 target enrollmentNovember 20, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Oral health looking at effects on breath
Sponsor
British American Tobacco
Enrollment
33
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 20, 2018
End Date
December 21, 2018
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Males or non\-pregnant, non\-lactating females, aged 21\-60 years inclusive. Age verification will be performed by checking government issued identification (e.g. passport or driving licence) during screening
  • 2\. Good general health as judged by the Investigator or their appropriately qualified designee based on medical history
  • 3\. Subjects will have given their written informed consent to participate in the study and will have agreed to abide by the study restrictions. Subjects must demonstrate the ability to comprehend the Informed Consent Form (ICF), be able to communicate well with the Investigator or their appropriately qualified designee, understand and comply with the requirements of the study, and be judged suitable for the study in the opinion of the Investigator or their appropriately qualified designee
  • 4\. Subjects will be willing to refrain from consuming alcohol within 48 hours prior to Screening and study visit
  • 5\. Subjects will be willing to refrain from consuming coffee, onions, garlic and spicy food, for 48 hours prior to test visit
  • 6\. Good oral health with no diseases or conditions which could affect the study/have an adverse impact on the volunteer including severe gingivitis, grossly carious lesions and periodontal disease
  • 7\. At least 12 natural teeth, with at least 1 tooth suitable for GCF sampling (in the opinion of the dentist) per quadrant
  • 8\. No scale and polish for 6 months prior to screening for all groups
  • 9\. SMOKERS:
  • 9\.1\. Subjects will be regular smokers of commercially manufactured filter cigarettes and including menthol cigarettes

Exclusion Criteria

  • 1\. Signs of gross or untreated caries or of significant periodontal disease, which, in the opinion of the study dentist, either would affect the scientific validity of the study or, if the subject were to participate in the study, would affect their wellbeing
  • 2\. Orthodontic or prosthetic appliances (fixed or removable), including dental implants
  • 3\. Tongue or lip piercing
  • 4\. Currently participating in other dental trials
  • 5\. Pregnant or breastfeeding women
  • 6\. Medical condition and/or regular use of any medication which might affect the outcome of the study including:
  • evidence or recent (within 4 weeks) history of bronchitis, tonsillitisor sinusitis, current respiratory infection, oesophageal reflux, colds, flu, sore throat, severe xerostomia, either self\-reported or evidenced through oral examination, diabetics, current use or use of any antibiotics within 14 days prior to screening
  • 7\. Medications or supplements which may impact oral mouth odour within 7 days prior to the test visit, specifically zinc\-containing products
  • 8\. Current use or use of anti\-inflammatory medication within 4 weeks of screening
  • 9\. Subjects who have a significant history of alcoholism or drug/chemical abuse within 24 months prior to Screening, as determined by the Investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials